Sign up to access historical data
Similar companies
| Company | Est. Transaction Value | |
|---|---|---|
 |
Gilead SciencesGILD |
$73,000 |
 |
BridgeBio PharmaBBIO |
$16,000 |
 |
Thermo Fisher ScientificTMO |
-$200,000 |
 |
NovartisNVS |
-$150,000 |
 |
IlluminaILMN |
$17,000 |
Trades by US Politicians
| Politician | Filing Date | Type | Size |
|---|---|---|---|
| David Taylor | Dec 3, 2025 | Sell | $1K - $15K |
| Marjorie Taylor Greene | Oct 24, 2025 | Buy | $1K - $15K |
| Lisa McClain | Sep 25, 2025 | Sell | $1K - $15K |
| Marjorie Taylor Greene | Sep 11, 2025 | Buy | $1K - $15K |
| Lisa McClain | Jun 24, 2025 | Buy | $1K - $15K |
| Cliff Bentz | Jun 6, 2025 | Buy | $1K - $15K |
| Marjorie Taylor Greene | May 14, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | May 12, 2025 | Sell | $15K - $50K |
| Marjorie Taylor Greene | May 5, 2025 | Buy | $1K - $15K |
| Jared Moskowitz | Apr 16, 2025 | Buy | $1K - $15K |
| Jefferson Shreve | Apr 11, 2025 | Buy | $15K - $50K |
| Jefferson Shreve | Feb 24, 2025 | Buy | $15K - $50K |
| Daniel Meuser | Feb 11, 2025 | Sell | $1K - $15K |
| Emily Randall | Jan 6, 2025 | Sell | $1K - $15K |
| Virginia Foxx | Dec 6, 2024 | Buy | $1K - $15K |
| Julia Letlow | Nov 19, 2024 | Sell | $1K - $15K |
| Julia Letlow | Oct 23, 2024 | Buy | $1K - $15K |
| Ro Khanna | Oct 14, 2024 | Buy | $1K - $15K |
| Ro Khanna | Sep 9, 2024 | Buy | $1K - $15K |
| Scott Mr Franklin | Aug 7, 2024 | Buy | $1K - $15K |
| C. Scott Franklin | Aug 7, 2024 | Buy | $50K - $100K |
| C. Scott Franklin | Aug 2, 2024 | Buy | $1K - $15K |
| Kathy Manning | Jul 2, 2024 | Buy | $1K - $15K |
| Rohit Khanna Democrat | May 29, 2024 | Sell | $15K - $50K |
| Rohit Khanna Democrat | Apr 16, 2024 | Buy | $15K - $50K |
FAQ - Congress Trading
David Taylor sold Amgen shares most recently on December 3, 2025.
C. Scott Franklin has bought the most AMGN stock in the last 2 years, with an estimated value of $83,000.
Jefferson Shreve has sold the most AMGN stock in the last 2 years, with an estimated value of $33,000.
According to our estimates, the net value of trades by US politicians for Amgen in the last 2 years is positive, amounting to $150,000. This indicates that US politicians have reasons to believe that the stock is going to go up.
Over the last 2 years, insider transactions for Amgen have predominantly involved purchasing shares, indicating a strong confidence among insiders in the company's future prospects. This trend of more purchases than sales could be a positive signal to potential investors about the politicians view on the company's future and growth potential.
Monitoring US politicians' stock trades is valuable because they may have inside information about upcoming policies that could affect stock values, providing investors with valuable clues for making informed decisions.
